{
    "root": "2f9c1aab-e0d4-c04e-e063-6294a90ab24c",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Paroxetine",
    "value": "20250305",
    "ingredients": [
        {
            "name": "POLYETHYLENE GLYCOL 6000",
            "code": "30IQX730WE"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "PAROXETINE HYDROCHLORIDE HEMIHYDRATE",
            "code": "X2ELS050D8"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "ANHYDROUS DIBASIC CALCIUM PHOSPHATE",
            "code": "L11K75P92J"
        },
        {
            "name": "ANHYDROUS LACTOSE",
            "code": "3SY5LH9PMK"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        }
    ],
    "indications": "Paroxetine tablets are indicated in adults for the treatment of:\n  \n• Major depressive disorder (MDD)\n  \n• Obsessive compulsive disorder (OCD)\n  \n• Panic disorder (PD)\n  \n• Social anxiety disorder (SAD)\n  \n• Generalized anxiety disorder (GAD)\n  \n• Posttraumatic stress disorder (PTSD)",
    "contraindications": "• Recommended starting and maximum daily dosage for MDD, OCD, PD, and PTSD: (2.2) Indication Starting Daily Dose Maximum Daily Dose MDD 20 mg 50 mg 0CD 20 mg 60 mg PD 10 mg 60 mg PTSD 20 mg 50 mg • Recommended starting dosage for SAD and GAD is 20 mg daily. (2.3) • Elderly patients, patients with severe renal impairment or severe hepatic impairment: Starting dosage is 10 mg daily. Maximum dosage is 40 mg daily. (2.4) • When discontinuing paroxetine tablets, reduce dosage gradually. (2.6, 5.7)",
    "warningsAndPrecautions": "Paroxetine Tablets USP, 10 mg are white to off-white, round-shaped, biconvex, film- coated tablets debossed with the logo of 'ZC, 15 and bisect' on one side and plain on other side, and are supplied as follows:\n                  \n                     \nBoxes of 10x10 UD 100 NDC 63739-888-10\n \n                  \n                     \nParoxetine Tablets USP, 20 mg are white to off-white, round-shaped, biconvex, film- coated tablets debossed with the logo of 'ZC, 16 and bisect' on one side and plain on other side, and are supplied as follows:\n \n                  \n                     \nBoxes of 10x10 UD 100 NDC 63739-963-10\n \n                  \n                     \n                     Storage\n                  \n                  \n                     \nStore at 20° to 25° C (68° to 77° F) [See USP Controlled Room Temperature].",
    "adverseReactions": "Paroxetine tablets are contraindicated in patients:\n  \n• Taking, or within 14 days of stopping, MAOIs (including the MAOIs linezolid and intravenous methylene blue) because of an increased risk of serotonin syndrome [see\n  \nWarnings and Precautions (5.2), Drug Interactions (7)].\n  \n• Taking thioridazine because of risk of QT prolongation [see Warnings and Precautions (5.3) and Drug Interactions (7)]\n  \n• Taking pimozide because of risk of QT prolongation [see Warnings and Precautions (5.3), Drug Interactions (7)].\n  \n• With known hypersensitivity (e.g., anaphylaxis, angioedema, Stevens-Johnson syndrome) to paroxetine or any of the inactive ingredients in paroxetine tablets [see\n  \nAdverse Reactions (6.1), (6.2)]."
}